Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lucidarme, N.
Right arrow Articles by Tubiana-Rufi, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lucidarme, N.
Right arrow Articles by Tubiana-Rufi, N.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Diabetes Care 28:710-711, 2005
© 2005 by the American Diabetes Association, Inc.


Clinical Care/Education/Nutrition
Brief Report

Alternate-Site Testing Is Reliable in Children and Adolescents With Type 1 Diabetes, Except at the Forearm for Hypoglycemia Detection

Nadine Lucidarme, MD1, Corinne Alberti, MD2, Isabelle Zaccaria, MD2, Emmanuel Claude, MD3 and Nadia Tubiana-Rufi, MD1

1 Department of Endocrinology, Robert Debre Teaching Hospital, AP-HP, Paris, France
2 Center of Clinical Epidemiology, Robert Debre Teaching Hospital, AP-HP, Paris, France
3 Ypsomed, Paris, France

Address correspondence and reprint requests to Dr. Nadine Lucidarme, Department of Endocrinology, Robert Debre Teaching Hospital, 75019 Paris, France. E-mail: nadine.lucidarme@jvr.ap-hop-paris.fr

Abbreviations: AST, alternate-site testing • SMBG, self-monitoring of blood glucose

The first 20% of the full text of this article appears below.


    INTRODUCTION
 
Self-monitoring of blood glucose (SMBG) is crucial to the management of type 1 diabetes (1,2). Until recently, SMBG relied only on capillary blood sampling by fingerstick (a source of pain) and other forms of patient discomfort likely to diminish adherence to SMBG. After approval of alternate-site testing (AST), clinical studies found differences across measurement sites (3) in diabetic adults experiencing rapid blood glucose variations (4). Although pediatric patients with type 1 diabetes may be particularly likely to benefit from new methods that decrease pain and other burdens associated with frequent SMBG, alternate-site SMBG in this age-group has not been fully validated.

The objectives of this study were to determine whether blood glucose measured at alternate testing sites (thenar and forearm) in diabetic children showed clinically significant differences compared with fingertip values and to evaluate patient satisfaction with AST.


    RESEARCH DESIGN AND METHODS
 
We included 29 children (aged 5–17 years) who had type 1 diabetes of at least 1 year’s duration and performed SMBG three or more times a day. The ethics . . . [Full Text of this Article]


    RESULTS
 

    CONCLUSIONS
 

Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am J Health Syst PharmHome page
S. M. Rivers, M. P. Kane, G. Bakst, R. S. Busch, and R. A. Hamilton
Precision and accuracy of two blood glucose meters: FreeStyle Flash versus One Touch Ultra.
Am. J. Health Syst. Pharm., August 1, 2006; 63(15): 1411 - 1416.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2005 by the American Diabetes Association.